PDE9A antibody (Internal Region)
Quick Overview for PDE9A antibody (Internal Region) (ABIN2469457)
Target
See all PDE9A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Internal Region
-
Specificity
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Purification
- Immunoaffinity Chromatography
-
Immunogen
- PDE9A antibody was raised against a peptide located near the internal domain of PDE9A (Human).
-
-
-
-
Application Notes
- PDE9A antibody can be used in ELISA, Western Blot, immunohistochemistry starting at 5 μg/mL, and immunofluorescence starting at 10 μg/mL.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, 0.1 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- As with all antibodies avoid freeze/thaw cycles.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- PDE9A antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.
-
-
- PDE9A (phosphodiesterase 9A (PDE9A))
-
Alternative Name
- PDE9A
-
Background
- Phosphodiesterase 9A is a cGMP-specific phosphodiesterase. PDE9A activity is inhibited by zaprinast, but it is insensitive to rolipram, vinpocetine, SKF-94120, dipyridamole, and IBMX. More than 20 alternatively spliced variants have been reported (Rentero et al. 2003). PDE9A has been implicated in penile erectile dysfunction, as well as in functional disturbances in which intraneuronal signal transmission via second messengers are important in the pathophysiology (example, bipolar affective disorder). PDE9A is the only cGMP-specific PDE with significant expression in the forebrain, and as such is likely to function in NO-cGMP signaling.
-
Gene ID
- 5152
-
UniProt
- O76083
Target
-